CVX · Chevron Corp

The shares of phantom stock issued under the Chevron Non-Employee Directors' Equity Compensation and Deferral Plan become payable in common stock upon the reporting person's termination of service.

1-for-1.

This number includes dividend equivalent accruals (4) under the Chevron Non-Employee Directors' Equity Compensation Plan.

The shares of phantom stock issued under the Chevron Non-Employee Directors' Equity Compensation and Deferral Plan become payable in common stock upon the reporting person's termination of service.

1-for-1.

This number includes dividend equivalent accruals (55) under the Chevron Non-Employee Directors' Equity Compensation and Deferral Plan.

This number represents stock units issued under the Chevron Corporation Non-Employee Directors' Equity Compensation and Deferral Plan.

This number includes the acquisition of dividend equivalent accruals on stock units (72) issued under the Chevron Corporation Non-Employee Directors' Equity Compensation and Deferral Plan.

This number represents stock units issued under the Chevron Corporation Non-Employee Directors' Equity Compensation and Deferral Plan.

This number includes the acquisition of dividend equivalent accruals on stock units (328) issued under the Chevron Corporation Non-Employee Directors' Equity Compensation and Deferral Plan.

This number represents stock units issued under the Chevron Corporation Non-Employee Directors' Equity Compensation and Deferral Plan.

This number represents stock units issued under the Chevron Corporation Non-Employee Directors' Equity Compensation and Deferral Plan.

This number includes the acquisition of dividend equivalent accruals on stock units (259) issued under the Chevron Corporation Non-Employee Directors' Equity Compensation and Deferral Plan.

This number represents stock units issued under the Chevron Corporation Non-Employee Directors' Equity Compensation and Deferral Plan.

This number includes the acquisition of dividend equivalent accruals on stock units (1,406) issued under the Chevron Corporation Non-Employee Directors' Equity Compensation and Deferral Plan.

This number represents stock units issued under the Chevron Corporation Non-Employee Directors' Equity Compensation and Deferral Plan.

This number includes the acquisition of dividend equivalent accruals on stock units (72) issued under the Chevron Corporation Non-Employee Directors' Equity Compensation and Deferral Plan and the acquisition of stock (98) through dividend reinvestment.

This number represents stock units issued under the Chevron Corporation Non-Employee Directors' Equity Compensation and Deferral Plan.

This number includes the acquisition of dividend equivalent accruals on stock units (55) issued under the Chevron Corporation Non-Employee Directors' Equity Compensation and Deferral Plan.

This number represents stock units issued under the Chevron Corporation Non-Employee Directors' Equity Compensation and Deferral Plan.

This number includes the acquisition of dividend equivalent accruals on stock units (789) issued under the Chevron Corporation Non-Employee Directors' Equity Compensation and Deferral Plan.

This number represents stock units issued under the Chevron Corporation Non-Employee Directors' Equity Compensation and Deferral Plan.

This number includes the acquisition of dividend equivalent accruals on stock units (501) issued under the Chevron Corporation Non-Employee Directors' Equity Compensation and Deferral Plan.

This number represents stock units issued under the Chevron Corporation Non-Employee Directors' Equity Compensation and Deferral Plan.

This number includes the acquisition of dividend equivalent accruals on stock units (4) issued under the Chevron Corporation Non-Employee Directors' Equity Compensation and Deferral Plan.

This number represents stock units issued under the Chevron Corporation Non-Employee Directors' Equity Compensation and Deferral Plan.

This number includes rounding of fractional shares.

These shares were sold in multiple transactions at prices ranging from $192.30 to $193.29, inclusive. The price reported in Column 4 reflects the weighted average sale price.

Shares are held by a trust established for the benefit of the reporting person and of which the reporting person is a beneficiary.

These shares were sold in multiple transactions at prices ranging from $195.30 to $196.29, inclusive. The price reported in Column 4 reflects the weighted average sale price.

Shares are held by a trust established for the benefit of the reporting person and of which the reporting person is a beneficiary.

These shares were sold in multiple transactions at prices ranging from $197.31 to $197.60, inclusive. The price reported in Column 4 reflects the weighted average sale price.

Shares are held by a trust established for the benefit of the reporting person and of which the reporting person is a beneficiary.

These shares were sold in multiple transactions at prices ranging from $193.30 to $194.295, inclusive. The price reported in Column 4 reflects the weighted average sale price.

Shares are held by a trust established for the benefit of the reporting person and of which the reporting person is a beneficiary.

These shares were sold in multiple transactions at prices ranging from $191.30 to $192.295, inclusive. The price reported in Column 4 reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and in footnotes (3) through (8) to this Form 4.

Shares are held by a trust established for the benefit of the reporting person and of which the reporting person is a beneficiary.

These shares were sold in multiple transactions at prices ranging from $194.30 to $195.29, inclusive. The price reported in Column 4 reflects the weighted average sale price.

Shares are held by a trust established for the benefit of the reporting person and of which the reporting person is a beneficiary.

These shares were sold in multiple transactions at prices ranging from $196.30 to $197.26, inclusive. The price reported in Column 4 reflects the weighted average sale price.

Shares are held by a trust established for the benefit of the reporting person and of which the reporting person is a beneficiary.

This number includes the acquisition of dividend equivalent accruals on stock units (121) issued under the Chevron Corporation Non-Employee Directors' Equity Compensation and Deferral Plan. The figure has also been adjusted to reflect the addition of 5 shares of common stock that were inadvertently omitted from the reporting person's prior Forms 4.

These shares were sold in multiple transactions at prices ranging from $185.14 to $185.60, inclusive. The price reported in Column 4 reflects the weighted average sale price.

Shares are held by a trust established for the benefit of the reporting person and of which the reporting person is a beneficiary.

These shares were sold in multiple transactions at prices ranging from $183.14 to $184.1375, inclusive. The price reported in Column 4 reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (3) through (4) to this Form 4.

Shares are held by a trust established for the benefit of the reporting person and of which the reporting person is a beneficiary.

These shares were sold in multiple transactions at prices ranging from $184.14 to $185.1399, inclusive. The price reported in Column 4 reflects the weighted average sale price.

Shares are held by a trust established for the benefit of the reporting person and of which the reporting person is a beneficiary.

Option granted 1/31/2018. One-third of the shares subject to the option vested on January 31, 2019, January 31, 2020 and January 31, 2021, respectively.

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 26, 2025.

This number includes the acquisition of stock resulting from the reinvestment of dividends on vested restricted stock units (80) issued under the Chevron Corporation 2022 Long-Term Incentive Plan.

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 26, 2025.

This transaction was executed in multiple trades at prices ranging from $213.10 to $213.82. The price reported above reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price within the range provided.

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 26, 2025.

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 26, 2025.

Option granted 1/30/2019. One-third of the shares subject to the option vested on January 31, 2020, January 31, 2021 and January 31, 2022, respectively.

These shares were sold in multiple transactions at prices ranging from $190.00 to $190.635, inclusive. The price reported in Column 4 reflects the weighted average sale price.

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 22, 2025.

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 26, 2025.

These shares were sold in multiple transactions at prices ranging from $187.31 to $188.30, inclusive. The price reported in Column 4 reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) through (5) to this Form 4.

Option granted 1/30/2019. One-third of the shares subject to the option vested on January 31, 2020, January 31, 2021 and January 31, 2022, respectively.

The shares of phantom stock issued under the Chevron Non-Employee Directors' Equity Compensation and Deferral Plan become payable in common stock upon the reporting person's termination of service.

1-for-1.

This number includes dividend equivalent accruals (4) under the Chevron Non-Employee Directors' Equity Compensation and Deferral Plan.

Option granted 1/30/2019. One-third of the shares subject to the option vested on January 31, 2020, January 31, 2021 and January 31, 2022, respectively.

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 26, 2025.

These shares were sold in multiple transactions at prices ranging from $187.63 to $188.59, inclusive. The price reported in Column 4 reflects the weighted average sale price.

These shares were sold in multiple transactions at prices ranging from $187.50 to $188.22, inclusive. The price reported in Column 4 reflects the weighted average sale price.

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 26, 2025.

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 22, 2025.

Option granted 1/27/2021. One-third of the shares subject to the option vested on January 31, 2022, January 31, 2023 and January 31, 2024, respectively.

Option granted 1/25/2023. One-third of the shares subject to the option vested on January 31, 2024, January 31, 2025 and January 31, 2026, respectively.

Option granted 1/29/2020. One-third of the shares subject to the option vested on January 31, 2021, January 31, 2022 and January 31, 2023, respectively.

This transaction was executed in multiple trades at prices ranging from $188.50 to $188.64. The price reported in Column 4 reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price within the range provided.

These shares were sold in multiple transactions at prices ranging from $187.50 to $188.45, inclusive. The price reported in Column 4 reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 1 and 2 to this Form 4.

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 26, 2025.

These shares were sold in multiple transactions at prices ranging from $188.64 to $189.62, inclusive. The price reported in Column 4 reflects the weighted average sale price.

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 26, 2025.

These shares were sold in multiple transactions at prices ranging from $189.31 to $190.12, inclusive. The price reported in Column 4 reflects the weighted average sale price.